AMERSA Talks

Cancer Pain in Addiction: Navigating Opioids, MOUD, and Survivorship

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 56:42

After you listen, please complete SAMHSA’s required Training and Technical Assistance (TTA) GPRA Post-Event Form. This form will gather satisfaction with the event to help improve future episodes.

For patients with cancer and substance use disorders, managing pain safely and effectively presents unique challenges. Clinicians must balance appropriate opioid prescribing with the risks of relapse, overdose, and fragmented care. This episode explores how addiction, oncology, and palliative care providers can work together to support both cancer treatment and recovery. Listeners will learn practical frameworks for managing cancer-related pain, coordinating care across specialties, and improving outcomes for patients navigating these intersecting and complex conditions.

Timestamps:

[06:42] Cancer Pain vs Other Pain
 [09:22] Patient Education and Safety
 [15:22] Active Use and MOUD Basics
 [18:33] Adjuvants During Treatment
 [20:47] Buprenorphine in Cancer Pain
 [25:25] Choosing Bupe Products and Doses
 [31:01] Methadone Logistics and Risks
 [41:19] Survivorship and Chronic Pain
 [48:39] Building Collaboration Systems
 [53:07] Key Takeaways and Resources

Links :

AMERSA

Opioid and Substance Use Disorder Training for DEA-Registered Clinicians | Center to Advance Palliative Care

Conversations that Matter: Engaging Patients around Pain and Substance Use - VitalTalk

14: Care at the Crossroads: Opioid Prescribing in Individuals with Serious Illness and Opioid Use Disorder - Providers Clinical Support System-Medications for Opioid Use Disorders

Virtual Workshop: Optimizing Buprenorphine for Pain and Substance Use Disorder - CAPC | Center to Advance Palliative Care

Find us online at amersa.org/amersa-podcast 

Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org.

Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.